A clinical trial that’s attempting to discover a cure for sickle cell disease has found a new gene therapy to be safe and successful in four patients.
Two of the patients were treated at Cleveland Clinic Children’s in Ohio, and doctors there are hopeful that their positive results will be borne out in future research.
“New treatments like this are critical for people who have sickle cell disease,” said researcher Dr. Rabi Hanna, director of the pediatric blood and bone marrow transplant program at Cleveland Clinic Children’s.
